-
Recent Posts
Recent Comments
Archives
- October 2012
- December 2011
- November 2011
- September 2011
- March 2011
- December 2010
- November 2010
- September 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- November 2009
- October 2009
- September 2009
- July 2009
- June 2009
- February 2009
- January 2009
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- February 2007
- December 2006
- November 2006
- October 2006
- August 2006
- April 2006
- March 2006
- December 2005
- November 2005
- July 2005
- March 2005
- February 2005
- January 2005
- December 2004
- November 2004
- October 2004
- September 2004
- August 2004
Categories
Meta
Monthly Archives: May 2008
Drug Safety Update: May 2008
The MHRA have issued May’s Drug Safety Update, including: Rimonabant (Acomplia): depression; psychiatric adverse reactions Exenatide (Byetta): risk of acute pancreatitis Has this reaction been reported before? Finding out about suspected adverse drug reactions reported to the MHRA Monitoring the … Continue reading
Posted in MHRA
Comments Off
Etanercept (Enbrel) and infections
The FDA note Amgen and Wyeth Pharmaceuticals’ revisions to prescribing information for etanercept: The revisions include a BOXED WARNING about infections, including serious infections leading to hospitalization or death that have been observed in patients treated with Enbrel. Infections have … Continue reading
Posted in FDA
Comments Off